Elotuzumab for Treatment of Multiple Myeloma (Literature Review)
Chemotherapy has been the main treatment option for multiple myeloma for several decades. However, a considerable increase in the life expectancy was observed in multiple myeloma patients when thalidomide, bortezomib and lenalidomide had been introduced into clinical practice. Nevertheless, the dise...
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Russo |
| Хэвлэсэн: |
Practical Medicine Publishing House
2016-10-01
|
| Цуврал: | Клиническая онкогематология |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://bloodjournal.ru/index.php/coh/article/view/513 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|